Mexicor

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2017
01220042017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Cardioprotective efficacy of coenzyme Q10 (CoQ10, ubidecarenone) and mexicor were evaluated on the 21st day of experimental… (More)
Is this relevant?
2013
2013
This open prospective randomized 16-week study of combined therapy of coronary heat disease (CHD) and and diabetes mellitus of… (More)
Is this relevant?
2009
2009
In experiments with mice closed in airtight and altitude chambers mexicor effectiveness against hypoxia was evident only at the… (More)
Is this relevant?
2009
2009
We examined a total of forty-four patients diagnosed with coronary artery disease who were subjected to coronary artery bypass… (More)
Is this relevant?
2008
2008
Sixty hypertensive patients (mean age 64.9 +/- 1.5) with acute ischemic stroke were randomized into 2 groups. Both groups… (More)
Is this relevant?
2007
2007
The authors have studied mexicor's efficacy in a comprehensive treatment of 25 patients suffering from atherosclerosis obliterans… (More)
Is this relevant?
2006
2006
AIM To study mexicor effects on functional activity of beta-cells, insulin resistance, lipid metabolism and lipid peroxidation in… (More)
Is this relevant?
2006
2006
The authors analyze their experience in the application of mexicor, a Russian cytoprotector, in 50patients with chronic coronary… (More)
Is this relevant?
2005
2005
Mexicor (5% solution and capsules) was used in 40 of 80 conventionally treated patients with acute myocardial infarction. The… (More)
Is this relevant?
2004
2004
AIM To study efficacy of cytoprotector mexicor in patients with unstable angina (UA), acute myocardial infarction (MI… (More)
Is this relevant?